SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?


To: RCMac who wrote (245)9/10/2000 5:26:07 PM
From: peter michaelson  Read Replies (2) | Respond to of 1833
 
Hmmmmm.

Sounds to me as if either

(1) the $30 million loss carryforward does include the $19.1 million from the patent liability, and that in fact the company will report something like $15 million in taxable gain this year, or

(2) in prior years, the patent liability was accrued for book purposes but never for tax purposes.

Seems like there is just one good way to find out for sure.

The second part of my original question is more material - is there any way for a distribution to be made without being taxable to the individual stockholder?

Seems to me I have heard of dissolutions, with distribution of all assets to the owners, as being a non-taxable event.

Thanks. Peter